Looking to expand your partner network with leading companies like Numab? Consider joining Inpart's global network for free.
News and Trends 31 Mar 2020
Swiss Biopharma Launches Second Cancer Antibody Deal with Japanese Pharma Giant
The Japanese heavyweight Ono Pharmaceutical has recruited Numab Therapeutics for a second time to co-develop a multi-specific antibody cancer treatment in a deal worth up to €246M (CHF 260M). The announcement follows a two-year collaboration between Ono and Numab announced in March 2017. Under the new agreement, which includes upfront and milestone payments, Ono has […]
